Tue, February 1, 2022

Chris Shibutani Initiated (AMLX) at Strong Buy and Held Target at $36 on, Feb 1st, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-36-on-feb-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Chris Shibutani of Goldman Sachs, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $36 on, Feb 1st, 2022.

Chris, nor any peers, have made any analyst calls on AMLX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30